check_circleStudy Completed

Postmenopause, Pharmacokinetics

Bayer Identifier:

91314

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate the bioavailability of Estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2)

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
15
Trial Dates
October 2003 - January 2004
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Climara (E2 transdermal, BAY86-5435)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

An open-label, randomized, crossover study to evaluate the bioavailability of estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2) in healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.